Correlation Between Bolt Biotherapeutics and Syros Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bolt Biotherapeutics and Syros Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bolt Biotherapeutics and Syros Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bolt Biotherapeutics and Syros Pharmaceuticals, you can compare the effects of market volatilities on Bolt Biotherapeutics and Syros Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bolt Biotherapeutics with a short position of Syros Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bolt Biotherapeutics and Syros Pharmaceuticals.
Diversification Opportunities for Bolt Biotherapeutics and Syros Pharmaceuticals
0.53 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Bolt and Syros is 0.53. Overlapping area represents the amount of risk that can be diversified away by holding Bolt Biotherapeutics and Syros Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Syros Pharmaceuticals and Bolt Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bolt Biotherapeutics are associated (or correlated) with Syros Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Syros Pharmaceuticals has no effect on the direction of Bolt Biotherapeutics i.e., Bolt Biotherapeutics and Syros Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bolt Biotherapeutics and Syros Pharmaceuticals
Given the investment horizon of 90 days Bolt Biotherapeutics is expected to generate 0.11 times more return on investment than Syros Pharmaceuticals. However, Bolt Biotherapeutics is 9.5 times less risky than Syros Pharmaceuticals. It trades about -0.28 of its potential returns per unit of risk. Syros Pharmaceuticals is currently generating about -0.11 per unit of risk. If you would invest 68.00 in Bolt Biotherapeutics on August 26, 2024 and sell it today you would lose (10.00) from holding Bolt Biotherapeutics or give up 14.71% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bolt Biotherapeutics vs. Syros Pharmaceuticals
Performance |
| Timeline |
| Bolt Biotherapeutics |
| Syros Pharmaceuticals |
Bolt Biotherapeutics and Syros Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bolt Biotherapeutics and Syros Pharmaceuticals
The main advantage of trading using opposite Bolt Biotherapeutics and Syros Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bolt Biotherapeutics position performs unexpectedly, Syros Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Syros Pharmaceuticals will offset losses from the drop in Syros Pharmaceuticals' long position.| Bolt Biotherapeutics vs. Eliem Therapeutics | Bolt Biotherapeutics vs. HCW Biologics | Bolt Biotherapeutics vs. Scpharmaceuticals | Bolt Biotherapeutics vs. Milestone Pharmaceuticals |
| Syros Pharmaceuticals vs. Surrozen | Syros Pharmaceuticals vs. Bolt Biotherapeutics | Syros Pharmaceuticals vs. Larimar Therapeutics | Syros Pharmaceuticals vs. Keros Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Other Complementary Tools
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |